Published June 3, 2018
| Version v1
Dataset
Open
NSD3-Short Represses E-cadherin Expression in A549 Lung Epithelial Cancer Cells
Description
SGC Open Notebook Project to Characterize the HMTase NSD3
Exp024 Objective: In a previous experiment (exp023), we show that siRNA-mediated knockdown of NSD3 increases expression of E-cadherin, a marker of epithelial cell identity. To determine which isoform of NSD3 is involved in promoting epithelial to mesenchymal transition, I have designed siRNA that targets either the long or short isoform and again use E-cadherin expression as a marker. Additionally, I have started using A549 lung epithelial cancer cells (https://www.atcc.org/Products/All/CCL-185) as my primary model. This cell line proliferates faster and is more amenable to in vitro experimentation than the H1299 cell line I was using previously.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
exp024.pdf
Files
(2.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6b4225813fba3f544703d3ffa051ac82
|
648.7 kB | Preview Download |
|
md5:471b4d884b42a9a4b9c6cba9a69b0414
|
1.9 MB | Download |